e-learning
resources
Paris 2018
Tuesday, 18.09.2018
Difficult-to-treat respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Outcomes of Fibrinolytic therapy for acute empyema.
T. Koizumi (Niigata, Japan), H. Moriyama (Niigata, Japan), T. Hirono (Niigata, Japan), T. Ohdaira (Niigata, Japan), T. Watanabe (Niigata, Japan)
Source:
International Congress 2018 – Difficult-to-treat respiratory infections
Session:
Difficult-to-treat respiratory infections
Session type:
Thematic Poster
Number:
4710
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Koizumi (Niigata, Japan), H. Moriyama (Niigata, Japan), T. Hirono (Niigata, Japan), T. Ohdaira (Niigata, Japan), T. Watanabe (Niigata, Japan). Outcomes of Fibrinolytic therapy for acute empyema.. 4710
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Intrapleural fibrinolytic treatment of empyemas
Source: Eur Respir J 2005; 26: Suppl. 49, 491s
Year: 2005
Comparision of side effects between thrombolytic and anticoagulation therapy in patients with Pulmonary Embolism
Source: Virtual Congress 2020 – Pulmonary embolism
Year: 2020
Intrapleural fibrinolytic treatment with streptokinase for empyema during pregnancy: 2 cases
Source: Annual Congress 2010 - Infections and pleural problems
Year: 2010
Experience of ozonotherapy in complex chemotherapy of acute nonspecific pleural empyema
Source: Annual Congress 2009 - Pleural problems, congenital lesions and novel technical devices
Year: 2009
Intrapleural streptokinase treatment of complicated parapneumonic effusions and empyemas
Source: Annual Congress 2013 –Lung infections: a clinical point of view
Year: 2013
Intrapleural urokinase in the management of empyema in children
Source: Eur Respir J 2004; 24: Suppl. 48, 620s
Year: 2004
Outcomes of patients on multiple vasopressor therapy
Source: Annual Congress 2010 - Pulmonary infections and sepsis
Year: 2010
Hemorrhagic complications of treatment in patients with pulmonary embolism
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016
Anticoagulant treatment for acute pulmonary embolism: a pathophysiology-based clinical approach
Source: Eur Respir J 2015; 45: 1142-1149
Year: 2015
Outcome and medical and surgical treatment in pleural empyema
Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention
Year: 2008
Thrombolytic therapy in cases with massive pulmonary thromboembolism
Source: Eur Respir J 2005; 26: Suppl. 49, 521s
Year: 2005
Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis
Source: ERJ Open Res, 3 (3) 00016-2017; 10.1183/23120541.00016-2017
Year: 2017
Intrapleural instillation of fibrinolytics in the treatment complicated pneumonia in children. Case study
Source: Eur Respir J 2002; 20: Suppl. 38, 591s
Year: 2002
Outcome during and after anticoagulant therapy in cancer patients with incidentally found pulmonary embolism
Source: Eur Respir J 2016; 48: 1360-1368
Year: 2016
Risk factors associated to surgical treatment of parapneumonic effusion and empyema
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013
A Comparison of Intrapulmonary Percussive Ventilation and conventional Chest Physical Therapy for COPD patients hospitalized for acute exacerbation
Source: International Congress 2017 – Airway clearance techniques and respiratory physiotherapy in hospitalized patients
Year: 2017
Thrombolytic therapy in massive pulmonary thromboembolism
Source: Eur Respir J 2002; 20: Suppl. 38, 237s
Year: 2002
Treatment of hemoptysis in inoperable patients with pulmonary aspergilloma: Value of percutaneous instillation of fluconazole
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013
Intrapleural streptokinase therapy in tubercular pleural effusions – Randomized controlled study
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013
Comparision of catheter-directed therapy with the systemic thrombolysis for the treatment of acute pulmonary embolism with right ventricular dysfunction
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept